Cancer Gene Therapy

Articles in 2006

The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells

L Kasman
P Lu
C Voelkel-Johnson
Original Article22 Dec 2006
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects

T Wenger
J Mattern
I Herr
Original Article22 Dec 2006
Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver

T Au
S Thorne
T R Reid
Original Article01 Dec 2006
Humoral and cellular immunity induced by tumor cell vaccine based on the chicken xenogeneic homologous matrix metalloproteinase-2

T Yi
Y-Q Wei
Y-S Wang
Original Article24 Nov 2006
A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma

F Watt
R Watanabe
K Funa
Original Article24 Nov 2006
Adenoviral-mediated interferon α overcomes resistance to the interferon protein in various cancer types and has marked bystander effects

X Zhang
Z Yang
W F Benedict
Original Article10 Nov 2006
Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis

M-A Shibata
J Morimoto
Y Otsuki
Original Article10 Nov 2006
Gene therapy targeting to tumor endothelium

M Bazan-Peregrino
L W Seymour
A L Harris
Review10 Nov 2006
Persistent mismatch repair deficiency following targeted correction of hMLH1

M B Weiss
M I Vitolo
K E Bachman
Original Article03 Nov 2006
Long-term follow-up of gene-marked CD34⁺ cells after autologous stem cell transplantation for multiple myeloma

E Alici
B Björkstrand
M S Dilber
Original Article03 Nov 2006
A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer

E Frau
C Magnon
C Bouquet
Original Article03 Nov 2006
Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients

E Brouwer
M J Havenga
P Sillevis Smitt
Original Article03 Nov 2006
A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy

Y-F Xu
L-P Zhu
G-X Xu
Original Article27 Oct 2006
Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model

H Dzojic
W-S Cheng
M Essand
Original Article20 Oct 2006
Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc

L C Boffa
G Cutrona
M Ferrarini
Short Communication20 Oct 2006
The effects of FasL on inflammation and tumor survival are dependent on its expression levels

A Wada
Y Tada
M Tagawa
Original Article20 Oct 2006
Protection of normal human reconstructed epidermis from UV by catalase overexpression

H R Rezvani
M Cario-André
A Taïeb
Original Article20 Oct 2006
CD4⁺CD25⁺ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge

L Elia
L Aurisicchio
F Palombo
Original Article20 Oct 2006
Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy

R Kim
M Emi
K Tanabe
Review13 Oct 2006
International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China

B A Guinn
J S Norris
A B Deisseroth
Meeting Report13 Oct 2006

Previous page
page 1
page 2
page 3
…
page 5
Next page

Search

Advanced search

Quick links